Evelyne Lopez-Crapez Selected Research

Evelyne Lopez-Crapez Research Topics

Disease

19	Neoplasms (Cancer) 02/2021 - 03/2006
11	Breast Neoplasms (Breast Cancer) 01/2020 - 03/2009
10	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 03/2009
4	Triple Negative Breast Neoplasms 10/2022 - 01/2011
4	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2011
3	Rectal Neoplasms (Rectal Cancer) 01/2017 - 07/2007
2	Adenocarcinoma 01/2021 - 05/2012
2	Brain Neoplasms (Brain Tumor) 01/2019 - 11/2016
1	Carcinoma (Carcinomatosis) 10/2023
1	Carcinogenesis 09/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Circulating Neoplastic Cells 01/2020
1	Microsatellite Instability 08/2016
1	Familial Breast Cancer 11/2013
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 03/2009
1	Disease Progression 03/2009

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 10/2022 - 03/2006
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2013
5	DNA (Deoxyribonucleic Acid)IBA 04/2014 - 03/2006
4	Cetuximab (Erbitux)FDA Link 01/2024 - 03/2009
3	ErbB Receptors (EGF Receptor)IBA 05/2012 - 01/2011
2	Trastuzumab (Herceptin)FDA Link 01/2021 - 03/2009
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2020 - 03/2009
2	Messenger RNA (mRNA)IBA 01/2017 - 06/2011
2	Protein Isoforms (Isoforms)IBA 01/2017 - 01/2017
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2016 - 01/2016
2	Cell-Free Nucleic AcidsIBA 04/2014 - 06/2013
2	Hormones (Hormone)IBA 11/2013 - 01/2011
1	PlatinumIBA 10/2023
1	folfirinoxIBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	Nuclear Receptor Interacting Protein 1IBA 09/2021
1	Transcription Factors (Transcription Factor)IBA 09/2021
1	Gemcitabine FDA Link 01/2021
1	Alpha-Ketoglutarate-Dependent Dioxygenase FTOIBA 01/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 12/2020
1	BRCA1 ProteinIBA 03/2020
1	B7-H1 AntigenIBA 03/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	LigandsIBA 01/2020
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	Circulating Tumor DNAIBA 10/2019
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2019
1	Blood Proteins (Serum Proteins)IBA 01/2019
1	Biological FactorsIBA 01/2019
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 02/2016
1	ElementsIBA 02/2016
1	AntigensIBA 01/2016
1	Tumor Biomarkers (Tumor Markers)IBA 01/2016
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2016
1	Carcinoembryonic AntigenIBA 01/2016
1	Plasminogen Activator Inhibitor 1IBA 11/2013
1	Tumor Suppressor p53-Binding Protein 1IBA 11/2013
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2013
1	Formaldehyde (Formol)FDA Link 01/2013
1	Fixatives (Pickling Agents)IBA 01/2013
1	Monoclonal AntibodiesIBA 05/2012
1	Phosphotransferases (Kinase)IBA 01/2012
1	tyrosine receptor (receptor, tyrosine)IBA 01/2012
1	Epidermal Growth Factor (EGF)IBA 01/2011
1	Fc gamma receptor IIAIBA 03/2009
1	Rituximab (Mabthera)FDA Link 03/2009
1	Growth Factor ReceptorsIBA 03/2009
1	Nuclear Proteins (Protein, Nuclear)IBA 07/2007
1	Codon (Codons)IBA 03/2006

Therapy/Procedure

8	Therapeutics 01/2022 - 01/2011
5	Drug Therapy (Chemotherapy) 01/2024 - 01/2016
2	Immunotherapy 10/2022 - 01/2020
2	Adjuvant Chemotherapy 02/2021 - 03/2020
2	Neoadjuvant Therapy 05/2012 - 07/2007
1	Precision Medicine 04/2014
1	Chemoradiotherapy 05/2012